Stryker CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE

11 Feb 2026

SYK

10-K: Stryker Reports Strong 2025 Growth Amid Strategic Acquisitions

Stryker Corporation achieved robust net sales and adjusted earnings growth in 2025, driven by strategic acquisitions and innovative product launches across its MedSurg, Neurotechnology, and Orthopaedics segments.

NYSE

12 Feb 2025

SYK

Stryker CORP

10-K: Stryker Reports 2024 Results, Announces Inari Acquisition and Spinal Implants Divestiture

Stryker Corporation's 2024 Form 10-K reveals a year of solid growth, strategic acquisitions, and a significant portfolio reorganization, alongside detailed financial performance and risk assessments.

NYSE

14 Feb 2024

SYK

Stryker CORP

10-K: Stryker Corporation Outlines Capital Stock and Debt Securities in 10-K Filing

Stryker Corporation's 10-K filing details the structure of its capital stock, including common and preferred shares, and describes various debt securities issued by the company.